Species differences in intestinal glucuronidation activities between humans, rats, dogs and monkeys
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Species differences in intestinal glucuronidation activities between humans, rats, dogs and monkeys
Authors
Keywords
-
Journal
XENOBIOTICA
Volume 44, Issue 3, Pages 205-216
Publisher
Informa UK Limited
Online
2013-08-21
DOI
10.3109/00498254.2013.828362
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Method for predicting human intestinal first-pass metabolism of UGT substrate compounds
- (2012) Takako Furukawa et al. XENOBIOTICA
- Impact of Intestinal Glucuronidation on the Pharmacokinetics of Raloxifene
- (2011) K. Kosaka et al. DRUG METABOLISM AND DISPOSITION
- Human Pharmacokinetic Prediction of UDP-Glucuronosyltransferase Substrates with an Animal Scale-Up Approach
- (2011) T. Deguchi et al. DRUG METABOLISM AND DISPOSITION
- Correlation of Intrinsic in vitro and in vivo Clearance for Drugs Metabolized by Hepatic UDP-glucuronosyltransferases in Rats
- (2011) Fumihiro Nakamori et al. Drug Metabolism and Pharmacokinetics
- Prediction of the Intestinal First-pass Metabolism of CYP3A and UGT Substrates in Humans from in vitro Data
- (2011) Haruka Nishimuta et al. Drug Metabolism and Pharmacokinetics
- Quantitative Prediction of Intestinal Glucuronidation of Drugs in Rats Using In Vitro Metabolic Clearance Data
- (2011) Takako Furukawa et al. Drug Metabolism and Pharmacokinetics
- In vitroandin vivosmall intestinal metabolism of CYP3A and UGT substrates in preclinical animals species and humans: species differences
- (2011) Hiroshi Komura et al. DRUG METABOLISM REVIEWS
- Quantitative Prediction of Intestinal Metabolism in Humans from a Simplified Intestinal Availability Model and Empirical Scaling Factor
- (2010) K. Kadono et al. DRUG METABOLISM AND DISPOSITION
- Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol
- (2010) In-Soo Yoon et al. XENOBIOTICA
- Contribution of the Different UDP-Glucuronosyltransferase (UGT) Isoforms to Buprenorphine and Norbuprenorphine Metabolism and Relationship with the Main UGT Polymorphisms in a Bank of Human Liver Microsomes
- (2009) K. Rouguieg et al. DRUG METABOLISM AND DISPOSITION
- Tissue-Specific mRNA Expression Profiles of Drug-Metabolizing Enzymes and Transporters in the Cynomolgus Monkey
- (2009) Masuhiro Nishimura et al. Drug Metabolism and Pharmacokinetics
- Determination of mRNA Expression of Human UDP-Glucuronosyltransferases and Application for Localization in Various Human Tissues by Real-Time Reverse Transcriptase-Polymerase Chain Reaction
- (2008) S. Ohno et al. DRUG METABOLISM AND DISPOSITION
- Prediction of Drug Clearance by Glucuronidation from in Vitro Data: Use of Combined Cytochrome P450 and UDP-Glucuronosyltransferase Cofactors in Alamethicin-Activated Human Liver Microsomes
- (2008) P. J. Kilford et al. DRUG METABOLISM AND DISPOSITION
- The "Albumin Effect" and Drug Glucuronidation: Bovine Serum Albumin and Fatty Acid-Free Human Serum Albumin Enhance the Glucuronidation of UDP-Glucuronosyltransferase (UGT) 1A9 Substrates but Not UGT1A1 and UGT1A6 Activities
- (2008) A. Rowland et al. DRUG METABOLISM AND DISPOSITION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now